About
John Hoekman, PhD, is a biotech founder and pharmaceutical scientist. He is co-founder and CEO of Junevity, a longevity-oriented siRNA therapeutics company focused on resetting gene networks in age-related and metabolic disease. He previously co-founded Impel NeuroPharma/Impel Pharma, where he served as CSO and later CEO, and he is also active as a QB3 advisor/mentor.
Areas of interest
biotechlongevitysiRNA therapeuticsRNA interferenceaging biologytype 2 diabetesobesityneurodegenerationintranasal drug deliveryCNS therapeutics